Evidence map›Paper›PMID 19158084›Full record

ArticleThe Journal of biological chemistry2009

HDAC6 modulates Hsp90 chaperone activity and regulates activation of aryl hydrocarbon receptor signaling.

Vikram D Kekatpure, Andrew J Dannenberg, Kotha Subbaramaiah

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. HSP90 multi-functionality in cancer.Frontiers in immunology · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Histone Deacetylases (HDACs) Guided Novel Therapies for T-cell lymphomas.International journal of medical sciences · 2019
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Mechanisms of Hsp90 regulation.The Biochemical journal · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Vikram D KekatpureDepartment of Medicine and the Weill Cornell Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA.
Andrew J Dannenberg
Kotha Subbaramaiah
Cornell University · USWeill Cornell Medical College in Qatar · QA

Funding

TARGETING COX-2 AND EGFR SIGNALING IN ORAL CARCINOGENESISP01CA106451 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LIPPMAN, SCOTT M · 2004 to 2009
$8.3M
NCI NIH HHS P01 CA106451
6 · The paper itself

Abstract

The aryl hydrocarbon receptor (AhR), a ligand-activated member of the basic helix-loop-helix family of transcription factors, binds with high affinity to polycyclic aromatic hydrocarbons (PAH) and the environmental toxin 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin). Most of the biochemical, biological, and toxicological responses caused by exposure to PAHs and polychlorinated dioxins are mediated, at least in part, by the AhR. The AhR is a client protein of Hsp90, a molecular chaperone that can be reversibly acetylated with functional consequences. The main objective of this study was to determine whether modulating Hsp90 acetylation would affect ligand-mediated activation of AhR signaling. Trichostatin A and suberoylanilide hydroxamic acid, two broad spectrum HDAC inhibitors, blocked PAH and dioxin-mediated induction of CYP1A1 and CYP1B1 in cell lines derived from the human aerodigestive tract. Silencing HDAC6 or treatment with tubacin, a pharmacological inhibitor of HDAC6, also suppressed the induction of CYP1A1 and CYP1B1. Inhibiting HDAC6 led to hyperacetylation of Hsp90 and loss of complex formation with AhR, cochaperone p23, and XAP-2. Inactivation or silencing of HDAC6 also led to reduced binding of ligand to the AhR and decreased translocation of the AhR from cytosol to nucleus in response to ligand. Ligand-induced recruitment of the AhR to the CYP1A1 and CYP1B1 promoters was inhibited when HDAC6 was inactivated. Mutation analysis of Hsp90 Lys(294) shows that its acetylation status is a strong determinant of interactions with AhR and p23 in addition to ligand-mediated activation of AhR signaling. Collectively, these results show that HDAC6 activity regulates the acetylation of Hsp90, the ability of Hsp90 to chaperone the AhR, and the expression of AhR-dependent genes. Given the established link between activation of AhR signaling and xenobiotic metabolism, inhibitors of HDAC6 may alter drug or carcinogen metabolism.

Indexed as

Signal TransductionAcetylationAryl Hydrocarbon HydroxylasesCell Line, TumorCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1Cytochrome P-450 Enzyme SystemDioxinsEnvironmental PollutantsEnzyme ActivationEnzyme InhibitorsHistone Deacetylase 6Histone Deacetylase InhibitorsHistone DeacetylasesHSP90 Heat-Shock ProteinsHumansAryl Hydrocarbon Hydroxylasesaryl hydrocarbon receptor-interacting proteinCYP1B1 protein, humanCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1Cytochrome P-450 Enzyme SystemDioxinsEnvironmental PollutantsEnzyme InhibitorsHDAC6 protein, humanHistone Deacetylase 6Histone Deacetylase InhibitorsHistone DeacetylasesHSP90 Heat-Shock ProteinsHydroxamic AcidsIntracellular Signaling Peptides and ProteinsIntramolecular OxidoreductasesPolycyclic Aromatic HydrocarbonsProstaglandin-E SynthasesReceptors, Aryl Hydrocarbontrichostatin AVorinostat

Identifiers

PMID19158084
PMCPMC2658039
OpenAlexW2068257081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.